Position in VTRS
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$29,476,583
+$3,210,806 QoQ
Shares Held
1,856,208
-4.5% QoQ
Ownership
0.162%
of shares outstanding
% of Portfolio
0.49%
of 13F equity value
Holder Rank
#62
of 1,016 holders
Holding Since
Dec 2021
6 quarters on record
Voting authority
Sole 72%
Shared 0%
None 28%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026WEDGE CAPITAL MANAGEMENT L L P/NC holds $47,806,751 across 8 Drug Manufacturers - Specialty & Generic names. VTRS ranks #1 (61.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
This page
|
1,856,208 | $29,476,583 | |
| 2 | BCRX |
Biocryst Pharmaceuticals Inc
|
380,801 | $3,808,010 | |
| 3 | SUPN |
Supernus Pharmaceuticals, Inc.
|
68,885 | $3,203,841 | |
| 4 | PBH |
Prestige Consumer Healthcare Inc.
|
61,203 | $2,893,065 | |
| 5 | COLL |
Collegium Pharmaceutical, Inc
|
71,523 | $2,589,132 | |
| 6 | PCRX |
Pacira BioSciences, Inc.
|
94,554 | $2,398,834 | |
| 7 | IRWD |
Ironwood Pharmaceuticals Inc
|
435,650 | $1,834,086 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
|
19,367 | $1,603,200 |
All Filings in VTRS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,476,583 | 1,856,208 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $26,265,777 | 1,944,173 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $33,343,602 | 2,678,201 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $23,666,346 | 2,390,540 | Shares | Sole | 2025-10-10 | |
| 2025-06-30 | $30,090,617 | 3,369,610 | Shares | Sole | 2025-07-11 | |
| 2021-12-31 | $35,397,510 | 2,616,224 | Shares | Sole | 2022-01-24 | |
| No filing history on record for this holder in this stock. | ||||||